Stallion Fluorochemicals kicked off Q1 FY27 with robust financial growth: Revenue up 12.78% YoY to ₹124.68 Cr, EBITDA surged 75.85% to ₹25.27 Cr, and PAT jumped 79.15% to ₹18.57 Cr.

This profit boost stemmed from a better product mix and strategic planning.

Management forecasts a 30-35% revenue CAGR for three years, expecting EBITDA margins to improve 3-4% medium-term.

Key projects are progressing: the Khalapur helium plant (1200 MTPA) starts next quarter, Mambattu facility by year-end, and the critical Bhilwara R32 plant (10,000 MT) aims for December 26 completion.

This aggressive expansion into high-value manufacturing positions the company for significant future earnings growth.